

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 8.30282835 |
| 2 | lipoprotein transport (GO:0042953) | 7.66261140 |
| 3 | exogenous drug catabolic process (GO:0042738) | 7.24964504 |
| 4 | drug transmembrane transport (GO:0006855) | 7.18748274 |
| 5 | regulation of guanylate cyclase activity (GO:0031282) | 7.07313333 |
| 6 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.44894593 |
| 7 | drug catabolic process (GO:0042737) | 6.42848888 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 6.26932503 |
| 9 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.06953739 |
| 10 | drug transport (GO:0015893) | 5.94797808 |
| 11 | hormone catabolic process (GO:0042447) | 5.84413033 |
| 12 | neurotransmitter biosynthetic process (GO:0042136) | 5.79485846 |
| 13 | quaternary ammonium group transport (GO:0015697) | 5.65692096 |
| 14 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.58597184 |
| 15 | drug metabolic process (GO:0017144) | 5.57090119 |
| 16 | intestinal absorption (GO:0050892) | 5.52556089 |
| 17 | histamine transport (GO:0051608) | 5.28959612 |
| 18 | regulation of bile acid biosynthetic process (GO:0070857) | 5.25164751 |
| 19 | bile acid and bile salt transport (GO:0015721) | 4.98375501 |
| 20 | cellular glucuronidation (GO:0052695) | 4.96185869 |
| 21 | tooth mineralization (GO:0034505) | 4.91457049 |
| 22 | organic cation transport (GO:0015695) | 4.87964261 |
| 23 | uronic acid metabolic process (GO:0006063) | 4.77584141 |
| 24 | glucuronate metabolic process (GO:0019585) | 4.77584141 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.68439349 |
| 26 | NADH metabolic process (GO:0006734) | 4.58292366 |
| 27 | neurotransmitter metabolic process (GO:0042133) | 4.43645943 |
| 28 | regulation of cGMP biosynthetic process (GO:0030826) | 4.33841128 |
| 29 | adhesion of symbiont to host cell (GO:0044650) | 4.29403639 |
| 30 | virion attachment to host cell (GO:0019062) | 4.29403639 |
| 31 | flavonoid metabolic process (GO:0009812) | 4.17287862 |
| 32 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.09897360 |
| 33 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.09897360 |
| 34 | endocrine process (GO:0050886) | 4.09897360 |
| 35 | fructose metabolic process (GO:0006000) | 3.94433396 |
| 36 | arginine metabolic process (GO:0006525) | 3.93202640 |
| 37 | meiotic chromosome segregation (GO:0045132) | 3.83235466 |
| 38 | histone H3-K36 demethylation (GO:0070544) | 3.83162253 |
| 39 | bile acid metabolic process (GO:0008206) | 3.81617228 |
| 40 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.76402242 |
| 41 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.68361872 |
| 42 | adhesion of symbiont to host (GO:0044406) | 3.66732227 |
| 43 | embryonic process involved in female pregnancy (GO:0060136) | 3.65811259 |
| 44 | bone trabecula formation (GO:0060346) | 3.63211401 |
| 45 | peptide catabolic process (GO:0043171) | 3.60134741 |
| 46 | vitamin A metabolic process (GO:0006776) | 3.59653096 |
| 47 | regulation of cGMP metabolic process (GO:0030823) | 3.58933442 |
| 48 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.57317365 |
| 49 | digestion (GO:0007586) | 3.56988776 |
| 50 | regulation of systemic arterial blood pressure (GO:0003073) | 3.56820668 |
| 51 | diacylglycerol metabolic process (GO:0046339) | 3.56348054 |
| 52 | phenol-containing compound catabolic process (GO:0019336) | 3.54163953 |
| 53 | urea cycle (GO:0000050) | 3.52529123 |
| 54 | fat-soluble vitamin metabolic process (GO:0006775) | 3.50827940 |
| 55 | regulation of cellular extravasation (GO:0002691) | 3.50802864 |
| 56 | urea metabolic process (GO:0019627) | 3.48276585 |
| 57 | lipoprotein metabolic process (GO:0042157) | 3.46795948 |
| 58 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.41587152 |
| 59 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.41052666 |
| 60 | urate metabolic process (GO:0046415) | 3.40909359 |
| 61 | alkaloid metabolic process (GO:0009820) | 3.40786194 |
| 62 | peptide hormone processing (GO:0016486) | 3.39896360 |
| 63 | proline biosynthetic process (GO:0006561) | 3.39862793 |
| 64 | carnitine shuttle (GO:0006853) | 3.36090381 |
| 65 | omega-hydroxylase P450 pathway (GO:0097267) | 3.34019637 |
| 66 | renal system process involved in regulation of blood volume (GO:0001977) | 3.33746323 |
| 67 | amino-acid betaine transport (GO:0015838) | 3.32976711 |
| 68 | carnitine transport (GO:0015879) | 3.32976711 |
| 69 | high-density lipoprotein particle remodeling (GO:0034375) | 3.32819861 |
| 70 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.29136363 |
| 71 | vitamin transport (GO:0051180) | 3.28416207 |
| 72 | glycosylceramide metabolic process (GO:0006677) | 3.27711437 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 3.18088870 |
| 74 | nitrogen cycle metabolic process (GO:0071941) | 3.14681258 |
| 75 | fatty acid transmembrane transport (GO:1902001) | 3.14175823 |
| 76 | C4-dicarboxylate transport (GO:0015740) | 3.13333471 |
| 77 | very long-chain fatty acid metabolic process (GO:0000038) | 3.11763814 |
| 78 | sphingomyelin metabolic process (GO:0006684) | 3.09139235 |
| 79 | positive regulation of cGMP metabolic process (GO:0030825) | 3.06243791 |
| 80 | phospholipid efflux (GO:0033700) | 3.05062654 |
| 81 | glycine transport (GO:0015816) | 3.02947460 |
| 82 | drinking behavior (GO:0042756) | 3.01758486 |
| 83 | sulfur compound transport (GO:0072348) | 3.01651624 |
| 84 | positive regulation of lipid catabolic process (GO:0050996) | 3.01308441 |
| 85 | proline metabolic process (GO:0006560) | 3.00583538 |
| 86 | azole transport (GO:0045117) | 2.99850902 |
| 87 | glycerol metabolic process (GO:0006071) | 2.98927506 |
| 88 | proline transport (GO:0015824) | 2.98762701 |
| 89 | carnitine transmembrane transport (GO:1902603) | 2.96824266 |
| 90 | homocysteine metabolic process (GO:0050667) | 2.94170698 |
| 91 | eosinophil chemotaxis (GO:0048245) | 2.93284558 |
| 92 | positive regulation of meiosis (GO:0045836) | 2.93203254 |
| 93 | cytidine metabolic process (GO:0046087) | 2.92012090 |
| 94 | cytidine catabolic process (GO:0006216) | 2.92012090 |
| 95 | cytidine deamination (GO:0009972) | 2.92012090 |
| 96 | arginine catabolic process (GO:0006527) | 2.91727795 |
| 97 | resolution of meiotic recombination intermediates (GO:0000712) | 2.90771969 |
| 98 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 2.89635526 |
| 99 | heme transport (GO:0015886) | 2.88694198 |
| 100 | macromolecular complex remodeling (GO:0034367) | 2.86934289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.58354689 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.50874937 |
| 3 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.42767676 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.19755662 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.74535276 |
| 6 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.40642310 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.40111314 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29554916 |
| 9 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.26038512 |
| 10 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.22648361 |
| 11 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.20158626 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.19918104 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17167215 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.14359006 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.12410758 |
| 16 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.95947473 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95069517 |
| 18 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.89953112 |
| 19 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.87994199 |
| 20 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.82549988 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.80006801 |
| 22 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.78986530 |
| 23 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.77851630 |
| 24 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.77152819 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72912785 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65554657 |
| 27 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.62777569 |
| 28 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.57306123 |
| 29 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.55690106 |
| 30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53834877 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48264601 |
| 32 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.38978648 |
| 33 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.35117705 |
| 34 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.34324970 |
| 35 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.31894539 |
| 36 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28399526 |
| 37 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27280306 |
| 38 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.26665144 |
| 39 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26047824 |
| 40 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.24127092 |
| 41 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.22069467 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19265873 |
| 43 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.18759629 |
| 44 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18295186 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16802404 |
| 46 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.15123536 |
| 47 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.14535623 |
| 48 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14163494 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.13195920 |
| 50 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12201294 |
| 51 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10905175 |
| 52 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.10609720 |
| 53 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08000831 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07521023 |
| 55 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07513807 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05280402 |
| 57 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04780016 |
| 58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04405713 |
| 59 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04252414 |
| 60 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04252414 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03716328 |
| 62 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.03599572 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03364084 |
| 64 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02377971 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00648944 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00171334 |
| 67 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.00149012 |
| 68 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.99148052 |
| 69 | NCOR_22424771_ChIP-Seq_293T_Human | 0.97359307 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97156003 |
| 71 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95402609 |
| 72 | P300_27268052_Chip-Seq_Bcells_Human | 0.95246502 |
| 73 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95073404 |
| 74 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.95014503 |
| 75 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94426445 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.94185346 |
| 77 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.91530441 |
| 78 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.91287766 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91245932 |
| 80 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91071178 |
| 81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90889087 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90038261 |
| 83 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.89260305 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89201439 |
| 85 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.87887503 |
| 86 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87859527 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86902857 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86772503 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86309905 |
| 90 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.85606476 |
| 91 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85338572 |
| 92 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.84848369 |
| 93 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.83763167 |
| 94 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.83490565 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83077289 |
| 96 | ERA_21632823_ChIP-Seq_H3396_Human | 0.81632341 |
| 97 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.81198437 |
| 98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81147697 |
| 99 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80565229 |
| 100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79971009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.73353464 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 5.33700259 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.77193991 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.71866255 |
| 5 | MP0005365_abnormal_bile_salt | 4.22479662 |
| 6 | MP0001666_abnormal_nutrient_absorption | 4.03859788 |
| 7 | MP0004147_increased_porphyrin_level | 3.57067877 |
| 8 | MP0003183_abnormal_peptide_metabolism | 3.47152971 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 3.30747871 |
| 10 | MP0009840_abnormal_foam_cell | 2.92570327 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 2.89900597 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.63269421 |
| 13 | MP0001664_abnormal_digestion | 2.31439748 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.23810113 |
| 15 | MP0004043_abnormal_pH_regulation | 2.13101273 |
| 16 | MP0003646_muscle_fatigue | 2.11448926 |
| 17 | MP0003252_abnormal_bile_duct | 2.00344668 |
| 18 | MP0009643_abnormal_urine_homeostasis | 1.98635478 |
| 19 | MP0005332_abnormal_amino_acid | 1.96011078 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.89891047 |
| 21 | MP0001873_stomach_inflammation | 1.86147889 |
| 22 | MP0010155_abnormal_intestine_physiology | 1.79650951 |
| 23 | MP0004858_abnormal_nervous_system | 1.73655681 |
| 24 | MP0008872_abnormal_physiological_respon | 1.63675766 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.58605802 |
| 26 | MP0003868_abnormal_feces_composition | 1.54210360 |
| 27 | MP0001764_abnormal_homeostasis | 1.51979956 |
| 28 | MP0003866_abnormal_defecation | 1.48220166 |
| 29 | MP0003718_maternal_effect | 1.44154530 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.43379998 |
| 31 | MP0005670_abnormal_white_adipose | 1.38569296 |
| 32 | MP0003329_amyloid_beta_deposits | 1.34343580 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.34146060 |
| 34 | MP0005409_darkened_coat_color | 1.21904056 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.20886369 |
| 36 | MP0005448_abnormal_energy_balance | 1.20654989 |
| 37 | MP0000538_abnormal_urinary_bladder | 1.20260459 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.16393783 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.14143250 |
| 40 | MP0005166_decreased_susceptibility_to | 1.12088827 |
| 41 | MP0002136_abnormal_kidney_physiology | 1.11423822 |
| 42 | MP0001663_abnormal_digestive_system | 1.08631544 |
| 43 | MP0000490_abnormal_crypts_of | 1.08329017 |
| 44 | MP0001765_abnormal_ion_homeostasis | 1.06197142 |
| 45 | MP0001440_abnormal_grooming_behavior | 1.05637055 |
| 46 | MP0003879_abnormal_hair_cell | 1.04419415 |
| 47 | MP0000604_amyloidosis | 0.99875141 |
| 48 | MP0000609_abnormal_liver_physiology | 0.97194668 |
| 49 | MP0001919_abnormal_reproductive_system | 0.96889479 |
| 50 | MP0000477_abnormal_intestine_morphology | 0.96788197 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 0.93256003 |
| 52 | MP0000230_abnormal_systemic_arterial | 0.88684715 |
| 53 | MP0001756_abnormal_urination | 0.87814869 |
| 54 | MP0000678_abnormal_parathyroid_gland | 0.86293143 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 0.86070881 |
| 56 | MP0002098_abnormal_vibrissa_morphology | 0.85485382 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 0.85172073 |
| 58 | MP0005381_digestive/alimentary_phenotyp | 0.84814642 |
| 59 | MP0002160_abnormal_reproductive_system | 0.83167170 |
| 60 | MP0004484_altered_response_of | 0.79870484 |
| 61 | MP0005535_abnormal_body_temperature | 0.79594852 |
| 62 | MP0008004_abnormal_stomach_pH | 0.79306208 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77613672 |
| 64 | MP0005266_abnormal_metabolism | 0.77101635 |
| 65 | MP0003195_calcinosis | 0.72393654 |
| 66 | MP0001188_hyperpigmentation | 0.72228617 |
| 67 | MP0009697_abnormal_copulation | 0.72203083 |
| 68 | MP0009764_decreased_sensitivity_to | 0.70944217 |
| 69 | MP0006138_congestive_heart_failure | 0.70625054 |
| 70 | MP0008775_abnormal_heart_ventricle | 0.70070884 |
| 71 | MP0009115_abnormal_fat_cell | 0.69858616 |
| 72 | MP0005319_abnormal_enzyme/_coenzyme | 0.67993795 |
| 73 | MP0001845_abnormal_inflammatory_respons | 0.67440819 |
| 74 | MP0005387_immune_system_phenotype | 0.66282057 |
| 75 | MP0001790_abnormal_immune_system | 0.66282057 |
| 76 | MP0005376_homeostasis/metabolism_phenot | 0.65802520 |
| 77 | MP0009642_abnormal_blood_homeostasis | 0.65251564 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 0.64195820 |
| 79 | MP0002971_abnormal_brown_adipose | 0.62284166 |
| 80 | MP0003045_fibrosis | 0.61925452 |
| 81 | MP0000566_synostosis | 0.58660364 |
| 82 | MP0008469_abnormal_protein_level | 0.57935657 |
| 83 | MP0005389_reproductive_system_phenotype | 0.57760370 |
| 84 | MP0000427_abnormal_hair_cycle | 0.56962858 |
| 85 | MP0001835_abnormal_antigen_presentation | 0.55520184 |
| 86 | MP0000470_abnormal_stomach_morphology | 0.55319312 |
| 87 | MP0005410_abnormal_fertilization | 0.55302447 |
| 88 | MP0004130_abnormal_muscle_cell | 0.54545502 |
| 89 | MP0003953_abnormal_hormone_level | 0.54406541 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.54160252 |
| 91 | MP0000249_abnormal_blood_vessel | 0.53777662 |
| 92 | MP0000462_abnormal_digestive_system | 0.52869237 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.47640054 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.46634310 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 0.46251464 |
| 96 | MP0005334_abnormal_fat_pad | 0.45082234 |
| 97 | MP0006082_CNS_inflammation | 0.43868996 |
| 98 | MP0002148_abnormal_hypersensitivity_rea | 0.43658410 |
| 99 | MP0002796_impaired_skin_barrier | 0.41375405 |
| 100 | MP0002822_catalepsy | 0.41261661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 9.58511786 |
| 2 | Abnormality of proline metabolism (HP:0010907) | 7.19551196 |
| 3 | Hydroxyprolinuria (HP:0003080) | 7.19551196 |
| 4 | Widely patent fontanelles and sutures (HP:0004492) | 6.27430649 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 6.26978119 |
| 6 | Malnutrition (HP:0004395) | 5.54802465 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.51947395 |
| 8 | Unilateral renal agenesis (HP:0000122) | 5.46867575 |
| 9 | Hyperglycinuria (HP:0003108) | 4.66966168 |
| 10 | Fat malabsorption (HP:0002630) | 4.54700342 |
| 11 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.40678462 |
| 12 | Confusion (HP:0001289) | 4.32500103 |
| 13 | Hypoplasia of the fovea (HP:0007750) | 4.27990970 |
| 14 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.27990970 |
| 15 | Wide cranial sutures (HP:0010537) | 4.23185604 |
| 16 | Abnormality of vitamin B metabolism (HP:0004340) | 4.09839852 |
| 17 | Acanthocytosis (HP:0001927) | 3.90629075 |
| 18 | Posterior subcapsular cataract (HP:0007787) | 3.89881497 |
| 19 | Bilateral microphthalmos (HP:0007633) | 3.86185976 |
| 20 | Chronic diarrhea (HP:0002028) | 3.73035235 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 3.68612299 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.68612299 |
| 23 | Metabolic alkalosis (HP:0200114) | 3.62220660 |
| 24 | Decreased circulating renin level (HP:0003351) | 3.58811144 |
| 25 | Aplasia cutis congenita (HP:0001057) | 3.57272740 |
| 26 | Pigmentary retinal degeneration (HP:0001146) | 3.56815569 |
| 27 | Abnormality of vitamin metabolism (HP:0100508) | 3.49701706 |
| 28 | Nephrolithiasis (HP:0000787) | 3.47050110 |
| 29 | Ileus (HP:0002595) | 3.38029765 |
| 30 | Abnormality of urine glucose concentration (HP:0011016) | 3.31626861 |
| 31 | Glycosuria (HP:0003076) | 3.31626861 |
| 32 | Abnormality of the fovea (HP:0000493) | 3.29835093 |
| 33 | Alkalosis (HP:0001948) | 3.24115255 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.21998774 |
| 35 | Xanthomatosis (HP:0000991) | 3.20197922 |
| 36 | Steatorrhea (HP:0002570) | 3.08214317 |
| 37 | Nausea (HP:0002018) | 3.04940512 |
| 38 | Hypolipoproteinemia (HP:0010981) | 2.89111273 |
| 39 | Fused cervical vertebrae (HP:0002949) | 2.81812586 |
| 40 | Increased purine levels (HP:0004368) | 2.80129327 |
| 41 | Hyperuricemia (HP:0002149) | 2.80129327 |
| 42 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.77360067 |
| 43 | Intrahepatic cholestasis (HP:0001406) | 2.76543187 |
| 44 | Cerebral palsy (HP:0100021) | 2.73146801 |
| 45 | Renal tubular acidosis (HP:0001947) | 2.71439347 |
| 46 | Hyperlipoproteinemia (HP:0010980) | 2.69565865 |
| 47 | Hyperammonemia (HP:0001987) | 2.67759891 |
| 48 | Proximal tubulopathy (HP:0000114) | 2.66588405 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.63237000 |
| 50 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.59794776 |
| 51 | Lower limb hyperreflexia (HP:0002395) | 2.59128540 |
| 52 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.57046406 |
| 53 | Gout (HP:0001997) | 2.56697784 |
| 54 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.55582234 |
| 55 | Mixed hearing impairment (HP:0000410) | 2.51503769 |
| 56 | Abnormality of the right ventricle (HP:0001707) | 2.50132992 |
| 57 | Subcapsular cataract (HP:0000523) | 2.48873167 |
| 58 | Abnormality of renin-angiotensin system (HP:0000847) | 2.47709762 |
| 59 | Delayed epiphyseal ossification (HP:0002663) | 2.45104410 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.43584055 |
| 61 | Abnormal glucose tolerance (HP:0001952) | 2.42366255 |
| 62 | Abdominal distention (HP:0003270) | 2.39079727 |
| 63 | Thin bony cortex (HP:0002753) | 2.38962395 |
| 64 | Megaloblastic anemia (HP:0001889) | 2.37686213 |
| 65 | Progressive inability to walk (HP:0002505) | 2.30631083 |
| 66 | Facial shape deformation (HP:0011334) | 2.27418677 |
| 67 | Potter facies (HP:0002009) | 2.27418677 |
| 68 | Enlarged epiphyses (HP:0010580) | 2.27065382 |
| 69 | Congenital sensorineural hearing impairment (HP:0008527) | 2.25858197 |
| 70 | Hyperactive renin-angiotensin system (HP:0000841) | 2.25789590 |
| 71 | Metabolic acidosis (HP:0001942) | 2.24965292 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 2.23610851 |
| 73 | Sensorimotor neuropathy (HP:0007141) | 2.21397144 |
| 74 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.20973555 |
| 75 | Hypophosphatemia (HP:0002148) | 2.18002047 |
| 76 | Epidermoid cyst (HP:0200040) | 2.17146265 |
| 77 | Abnormality of the parietal bone (HP:0002696) | 2.14252037 |
| 78 | Hyperbilirubinemia (HP:0002904) | 2.08850163 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99640912 |
| 80 | Renal tubular dysfunction (HP:0000124) | 1.98951705 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 1.95582251 |
| 82 | Abnormal urine phosphate concentration (HP:0012599) | 1.91113484 |
| 83 | Pancreatitis (HP:0001733) | 1.90658686 |
| 84 | Focal segmental glomerulosclerosis (HP:0000097) | 1.83709282 |
| 85 | Hyperphosphaturia (HP:0003109) | 1.81402535 |
| 86 | Poikilocytosis (HP:0004447) | 1.80986714 |
| 87 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.80032950 |
| 88 | Hypokalemia (HP:0002900) | 1.79662173 |
| 89 | Hypophosphatemic rickets (HP:0004912) | 1.79390965 |
| 90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.76222199 |
| 91 | Hyperparathyroidism (HP:0000843) | 1.67858489 |
| 92 | Inability to walk (HP:0002540) | 1.67705129 |
| 93 | Right ventricular cardiomyopathy (HP:0011663) | 1.66845900 |
| 94 | Protuberant abdomen (HP:0001538) | 1.65648312 |
| 95 | Hemorrhage of the eye (HP:0011885) | 1.65050776 |
| 96 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.64241304 |
| 97 | Metaphyseal irregularity (HP:0003025) | 1.60972167 |
| 98 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.60922899 |
| 99 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.59311797 |
| 100 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.59000726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 7.20984331 |
| 2 | ACVR1B | 6.40546260 |
| 3 | BMPR2 | 4.59465666 |
| 4 | PINK1 | 3.70909644 |
| 5 | TLK1 | 3.59296402 |
| 6 | SIK3 | 2.60446953 |
| 7 | MST1R | 2.22197480 |
| 8 | ERN1 | 2.06275122 |
| 9 | MAP3K11 | 1.99378329 |
| 10 | MAP3K7 | 1.98254699 |
| 11 | PRKG2 | 1.96445841 |
| 12 | SIK2 | 1.96137803 |
| 13 | NEK2 | 1.95329925 |
| 14 | ERBB2 | 1.89927646 |
| 15 | SIK1 | 1.82730061 |
| 16 | ICK | 1.74397842 |
| 17 | RIPK1 | 1.66773880 |
| 18 | OXSR1 | 1.50746307 |
| 19 | STK11 | 1.50546300 |
| 20 | MAP3K12 | 1.42686024 |
| 21 | EEF2K | 1.33201393 |
| 22 | DAPK2 | 1.32253354 |
| 23 | MAP3K10 | 1.31060487 |
| 24 | EPHA2 | 1.28205575 |
| 25 | MELK | 1.25820410 |
| 26 | PIK3CA | 1.25088367 |
| 27 | STK39 | 1.23127824 |
| 28 | PRKAA2 | 1.21517261 |
| 29 | MET | 1.18325351 |
| 30 | MAPKAPK3 | 1.13234754 |
| 31 | TIE1 | 1.11609058 |
| 32 | BTK | 1.08010068 |
| 33 | ADRBK2 | 1.00954804 |
| 34 | MST4 | 0.97175264 |
| 35 | MAP3K1 | 0.95553361 |
| 36 | MARK3 | 0.93028073 |
| 37 | TNIK | 0.90374540 |
| 38 | CDC42BPA | 0.84538369 |
| 39 | MATK | 0.82822463 |
| 40 | STK3 | 0.78730833 |
| 41 | GRK1 | 0.78653570 |
| 42 | STK38 | 0.78508411 |
| 43 | PTK6 | 0.77436642 |
| 44 | MAPKAPK5 | 0.75029882 |
| 45 | PRKCZ | 0.73477172 |
| 46 | MYLK | 0.70026268 |
| 47 | PRKACG | 0.68221598 |
| 48 | MAP3K2 | 0.68150293 |
| 49 | IRAK1 | 0.65142168 |
| 50 | PDPK1 | 0.64822491 |
| 51 | MAP3K3 | 0.63838723 |
| 52 | BCR | 0.63735765 |
| 53 | MAP4K1 | 0.59133510 |
| 54 | FRK | 0.58919790 |
| 55 | PDK2 | 0.58729965 |
| 56 | PRKAA1 | 0.56609013 |
| 57 | PRKCA | 0.56367625 |
| 58 | SYK | 0.55349990 |
| 59 | GRK6 | 0.53669521 |
| 60 | PRKCI | 0.53100885 |
| 61 | TAOK3 | 0.52919440 |
| 62 | TYK2 | 0.50316134 |
| 63 | EPHA4 | 0.48797169 |
| 64 | EPHB2 | 0.47881147 |
| 65 | STK38L | 0.46099691 |
| 66 | CAMK4 | 0.43251693 |
| 67 | TEC | 0.42359262 |
| 68 | RPS6KA6 | 0.40785457 |
| 69 | AKT3 | 0.39675811 |
| 70 | TESK2 | 0.39521978 |
| 71 | PIM1 | 0.38930775 |
| 72 | MAP2K2 | 0.38331885 |
| 73 | NLK | 0.37267567 |
| 74 | MAPK7 | 0.35711159 |
| 75 | MAPK11 | 0.34610217 |
| 76 | EPHA3 | 0.33890606 |
| 77 | DAPK1 | 0.33588879 |
| 78 | WNK4 | 0.32936297 |
| 79 | ILK | 0.32500674 |
| 80 | PDK1 | 0.32201601 |
| 81 | PIK3CG | 0.31950175 |
| 82 | FGFR4 | 0.31435444 |
| 83 | IGF1R | 0.30120481 |
| 84 | ITK | 0.30093362 |
| 85 | FLT3 | 0.29862348 |
| 86 | MAPK4 | 0.28559527 |
| 87 | MAP2K1 | 0.28284799 |
| 88 | EPHB1 | 0.27390152 |
| 89 | DDR2 | 0.26037959 |
| 90 | TXK | 0.25843415 |
| 91 | CAMK2D | 0.24389624 |
| 92 | ADRBK1 | 0.23351316 |
| 93 | MUSK | 0.22199513 |
| 94 | CAMK2A | 0.22089959 |
| 95 | MAP2K6 | 0.21535676 |
| 96 | JAK3 | 0.21501038 |
| 97 | RET | 0.21059491 |
| 98 | PRKCD | 0.20884749 |
| 99 | CDK19 | 0.20367719 |
| 100 | IRAK4 | 0.20316795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.35773667 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.99395865 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.89375455 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.40764896 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.36878666 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.88054610 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.68743627 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.52425642 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.48755275 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48088161 |
| 11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.42638469 |
| 12 | Mineral absorption_Homo sapiens_hsa04978 | 2.41376007 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39556951 |
| 14 | Retinol metabolism_Homo sapiens_hsa00830 | 2.35134671 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.30949695 |
| 16 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.19396869 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.19058660 |
| 18 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.13756518 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.09085846 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.04523693 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93965768 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86133448 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.81946312 |
| 24 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.72031416 |
| 25 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.68892199 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.48710684 |
| 27 | Galactose metabolism_Homo sapiens_hsa00052 | 1.48680211 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.47007749 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37646637 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32048789 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28344654 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25067953 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.16798691 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.16617812 |
| 35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.12326462 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05574724 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04163156 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 1.01846735 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01174698 |
| 40 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90421738 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 0.80055458 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76711060 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70432372 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68380281 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64016116 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 0.63765297 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 0.63267532 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.61861190 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58355550 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57362547 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56892337 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55455223 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54901345 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54851493 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54737239 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.54243267 |
| 57 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53891312 |
| 58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53150198 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51915654 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51199258 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46161758 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45678363 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44157519 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.42901335 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42711451 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41835631 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41166601 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39857532 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38163274 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.33311510 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.33201895 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31363917 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.30211094 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29892714 |
| 75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.29886376 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.29816675 |
| 77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.29360732 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.29221293 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28073457 |
| 80 | Insulin secretion_Homo sapiens_hsa04911 | 0.27673409 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.26362220 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.25866990 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.24653739 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24129756 |
| 85 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.20046866 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.18660592 |
| 87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.17979586 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.16344634 |
| 89 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.15312914 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14550288 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.11012291 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.10986421 |
| 93 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.10039153 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.09486002 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09169362 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.09095435 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.09074645 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.07063587 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.06870837 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.04928677 |

